Patent · US Expired

3-[N-(Lower alkyl)-N-(tetrahydro-3-thienyl 5,5-dioxide)]sydnonimines

US4436743A · kind A · utility

9Cited by
3References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 19, 1982
Grant dateMar 13, 1984
Priority date
Expiry dateFeb 19, 2002

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P9/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Pharmacologically-active 3-aminosydnonimines (which are optionally substituted in the N.sup.6 -position) and their physiologically-acceptable acid-addition salts are compounded into standard dosage-form medicament compositions and are useful for prophylaxis for and treatment of cardiovascular-system disorders, such as high blood pressure and angina pectoris. The 3-aminosydnonimines are 3-[4-(lower alkoxy)carbonylpiperazin-1-yl]sydnonimines and 3-[N-(lower alkyl)-N-(tetrahydro-3-thienyl S,S-dioxide)]-sydnonimines.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.